Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...